Alteration of Wnt3a overexpression and its early monitoring value during hepatocellular carcinogenesis.
10.3760/cma.j.cn501113-20211223-00612
- Author:
Min YAO
1
;
Jian Jun WANG
2
;
Ling Ling WANG
3
;
Yan Yan QIN
3
;
Wen Li SAI
4
;
Li WANG
3
;
Shui Jie SHEN
5
;
Dengfu YAO
4
Author Information
1. Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China Department of Immunology, Medical School of Nantong University, Nantong 226001, China.
2. Jiangsu Nantong Higher Vocational and Technical School of Health, Nantong 226016.
3. Department of Immunology, Medical School of Nantong University, Nantong 226001, China.
4. Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
5. Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China Department of Oncology, Nantong Hospital of Traditional Chinese Medicine, Nantong 226001, China.
- Publication Type:Journal Article
- MeSH:
Rats;
Animals;
Carcinoma, Hepatocellular/pathology*;
Liver Neoplasms/pathology*;
Rats, Sprague-Dawley;
Carcinogenesis/metabolism*;
2-Acetylaminofluorene;
RNA, Messenger/metabolism*;
Precancerous Conditions
- From:
Chinese Journal of Hepatology
2022;30(9):947-953
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the dynamic expression pattern of carcinoembryonic Wnt3a and its early monitoring value using a hepatocellular carcinoma model. Methods: Forty-eight Sprague Dawley (SD) rats were fed with pellet feed containing 2-acetylaminofluorene (2-AAF, 0.05%) to induce hepatocarcinogenesis, and control rats were fed a pellet diet. Liver tissue and blood samples were collected every two weeks. Liver tissues were pathologically examined using HE staining and grouped. The gene and Wnt3a mRNA expression were analyzed by genome-wide microarray. The expression and distribution of Wnt3a in liver tissue were analyzed by immunohistochemistry. Wnt3a concentration in liver tissue and serum was quantified by enzyme-linked immunosorbent assay. Statistical methods such as χ2 test, Mann-Whitney test and analysis of variance were used to analyze the differences between groups. Results: According to the pathological examination results, the rat livers were divided into four groups: control, hepatocyte degeneration, precancerous lesions and hepatocellular carcinoma. Genome-wide expression profiling analysis and comparison with the control group revealed that 268 and 312 genes were up-regulated and 57 and 201 genes were down-regulated in the precancerous and cancerous group when signal logarithm ratio (SLR) was >8 log2cy5/cy3, and these significantly altered genes mainly involved in cell proliferation, signal transduction, tumor metastasis, and apoptosis. The expression of Wnt3a at mRNA level was significantly increased in all stages of cancer induction, including degeneration group (1.15±0.24, q=8.227), precancerous group (1.85±0.18, q=12.361) and cancerous group (2.59±0.55, q=18.082). Compared with the control group (0.25±0.11, F=121.103, P<0.001), the degeneration group, the precancerous group and the liver cancer group were up-regulated by 4.6, 7.4 and 10.4-folds, respectively. Immunohistochemistry showed that compared with the control group, the positive rate of Wnt3a in the degeneration group was 66.7% (12/18, χ2=10.701, P=0.001), and both the precancerous and liver cancer groups were positive (9/9, χ2=17.115, P<0.001). Wnt3a expression was gradually increased in liver and blood samples during the process of carcinogenesis, and the difference between two groups was statistically significant (F=176.711, P<0.001). Wnt3a overexpression was secreted into blood stream via cancerous liver tissue, and there was a linear correlation between Wnt3a levels in blood and liver samples (r=0.732, P<0.001). Conclusions: Wnt3a overexpression is closely related with hepatocellular carcinogenesis, and thus may become a new monitoring marker.
